Drug · DIN 02239911
PLAS+SD
No: no longer authorized
The company stopped selling it and its DIN was cancelled. A cancellation is most often a business decision; the record does not say why.
Status Cancelled Post Market since October 27, 2003; first marketed October 13, 1999.
- Drug Identification Number (DIN)
- 02239911
- Company (DIN owner)
- Precision Pharma Services, Inc.Melville, New York, United States
- Schedule
- Schedule D
- Dosage form
- Liquid
- Route
- Intravenous
- Therapeutic class (ATC)
- Other plasma protein fractions B05AA02
- Class
- Human
- Record last updated
- March 22, 2025
Active ingredients
As listed in the Drug Product Database.
| Ingredient | Strength | Per |
|---|---|---|
| HUMAN PLASMA | 200 ML | PCK |
Notices of Compliance
Health Canada approvals that name this DIN.
- October 16, 2001: NOC 2304New Drug Submission (NDS) · Manufacturer name change
- June 16, 1999: NOC 1993New Drug Submission (NDS)